Cardinal Health price to free cash flow CAH
Market value divided by free cash flow over the last twelve months, since 2010.
- Today, Oct 23, 2026
- 12.8×
- 10-year median
- 9.3×
- Against its 10-year history
- 77th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 4.6× to 40.1×
- Peer median
- 16.6×
Cardinal Health's price to free cash flow is 12.8× as of Oct 23, 2026.
That is above its ten-year median of 9.3×, higher than on 77% of days in the last ten years.
Over that time it ranged from 4.6× in May 2023 to 40.1× in Jun 2017.
The median for 3 medical distribution stocks of a similar size is 16.6×.
Price to free cash flow over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 12.8× | 8.5× | 13.1× |
| 2025 | 11.1× | 10.2× | 29.4× |
| 2024 | 27.2× | 7.3× | 28.0× |
| 2023 | 8.7× | 4.6× | 9.9× |
| 2022 | 5.9× | 5.8× | 37.6× |
| 2021 | 12.9× | 5.0× | 12.9× |
| 2020 | 6.3× | 6.1× | 11.6× |
| 2019 | 11.1× | 5.1× | 12.1× |
| 2018 | 8.4× | 5.8× | 13.6× |
| 2017 | 10.3× | 8.8× | 40.1× |
| 2016 | 8.7× | 7.9× | 13.3× |
| 2015 | 14.1× | 11.5× | 20.2× |
| 2014 | 19.7× | 10.6× | 20.0× |
| 2013 | 12.0× | 11.1× | 15.9× |
| 2012 | 13.9× | 10.1× | 15.4× |
| 2011 | 10.0× | 8.1× | 14.2× |
| 2010 | 8.0× | 5.8× | 8.2× |
Against its peers
Companies in Medical - Distribution nearest Cardinal Health's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| CAHCardinal Health | 12.8× |
| CORCencora | 15.6× |
| MCKMcKesson | 18.2× |
| HSICHenry Schein | 16.6× |
| Peer median | 16.6× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Cardinal Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.